Full text
PDF![49](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/00b26ae81f9d/bripharmchem00041-0055.png)
![50](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/6aab9aa388a0/bripharmchem00041-0056.png)
![51](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/cea603606ac7/bripharmchem00041-0057.png)
![52](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/8c2a8ae0939a/bripharmchem00041-0058.png)
![53](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/6d565468a0a6/bripharmchem00041-0059.png)
![54](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/0ff2994fc0e8/bripharmchem00041-0060.png)
![55](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/34a6ee48069f/bripharmchem00041-0061.png)
![56](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/6f593472723f/bripharmchem00041-0062.png)
![57](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/b8a48f803747/bripharmchem00041-0063.png)
![58](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/acbffa1a447f/bripharmchem00041-0064.png)
![59](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/b9090b57cca9/bripharmchem00041-0065.png)
![60](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/1b974b709363/bripharmchem00041-0066.png)
![61](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/8aec78878ed0/bripharmchem00041-0067.png)
![62](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/7c3dcb2a7d17/bripharmchem00041-0068.png)
![63](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/22a98315bc86/bripharmchem00041-0069.png)
![64](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/8632f9cdc339/bripharmchem00041-0070.png)
![65](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/a95a4eb716bd/bripharmchem00041-0071.png)
![66](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/fe257484b96e/bripharmchem00041-0072.png)
![67](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e831/1704069/e1e47541c5e4/bripharmchem00041-0073.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BOGDANSKI D. F., PLETSCHER A., BRODIE B. B., UNDENFRIEND S. Identification and assay of serotonin in brain. J Pharmacol Exp Ther. 1956 May;117(1):82–88. [PubMed] [Google Scholar]
- BOGDANSKI D. F., WEISSBACH H., UDENFRIEND Pharmacological studies with the serotonin precursor, 5-hydroxytryptophan. J Pharmacol Exp Ther. 1958 Feb;122(2):182–194. [PubMed] [Google Scholar]
- BRODIE B. B., TOMICH E. G., KUNTZMAN R., SHORE P. A. On the mechanism of action of reserpine: effect of reserpine on capacity of tissues to bind serotonin. J Pharmacol Exp Ther. 1957 Apr;119(4):461–467. [PubMed] [Google Scholar]
- CORNE S. J., PICKERING R. W., WARNER B. T. A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1963 Feb;20:106–120. doi: 10.1111/j.1476-5381.1963.tb01302.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DUBNICK B., LEESON G. A., CHESSIN M., SCOTT C. C. Accumulation of serotonin in the brain of reserpine-treated mice after inhibition of monoamine oxidase: effect of body temperature. Arch Int Pharmacodyn Ther. 1960 Jun 1;126:194–202. [PubMed] [Google Scholar]
- GEY K. F., PLETSCHER A. Effect of alpha-alkylated tryptamine derivatives on 5-hydroxytryptamine metabolism in vivo. Br J Pharmacol Chemother. 1962 Aug;19:161–167. doi: 10.1111/j.1476-5381.1962.tb01437.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GREIG M. E., WALK R. A., GIBBONS A. J. The effect of three tryptamine derivatives on serotonin metabolism in vitro and in vivo. J Pharmacol Exp Ther. 1959 Oct;127:110–115. [PubMed] [Google Scholar]
- LESSIN A. W., LONG R. F., PARKES M. W. THE EFFECTS OF ALPHA-ALKYL SUBSTITUTED TRYPTAMINES ON 5-HYDROXYTRYPTAMINE UPTAKE BY BLOOD PLATELETS. Br J Pharmacol Chemother. 1965 Feb;24:68–75. doi: 10.1111/j.1476-5381.1965.tb02080.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LESSIN A. W., PARKES M. W. The effects of reserpine and other agents upon leptazol convulsions in mice. Br J Pharmacol Chemother. 1959 Mar;14(1):108–111. doi: 10.1111/j.1476-5381.1959.tb00935.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LESSIN A. W., PARKES M. W. The relation between sedation and body temperature in the mouse. Br J Pharmacol Chemother. 1957 Jun;12(2):245–250. doi: 10.1111/j.1476-5381.1957.tb00128.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LESSIN A. W. The pharmacological evaluation of monoamine oxidase inhibitors. Biochem Pharmacol. 1959 Nov;2:290–298. doi: 10.1016/0006-2952(59)90043-7. [DOI] [PubMed] [Google Scholar]
- TAYLOR J. D., WYKES A. A., GLADISH Y. C., MARTIN W. B. New inhibitor of monoamine oxidase. Nature. 1960 Sep 10;187:941–942. doi: 10.1038/187941a0. [DOI] [PubMed] [Google Scholar]
- TEDESCHI D. H., TEDESCHI R. E., FOWLER P. J., GREEN H., FELLOWS E. J. N-Methyl-alpha-methyl-tryptamine: a potent monoamine oxidase inhibitor and tryptamine antagonist. Biochem Pharmacol. 1962 Jun;11:481–485. doi: 10.1016/0006-2952(62)90231-9. [DOI] [PubMed] [Google Scholar]
- UDENFRIEND S., WEISSBACH H., BOGDANSKI D. F. Effect of iproniazid on serotonin metabolism in vivo. J Pharmacol Exp Ther. 1957 Jun;120(2):255–260. [PubMed] [Google Scholar]
- UDENFRIEND S., WEISSBACH H., BOGDANSKI D. F. Increase in tissue serotonin following administration of its precursor 5-hydroxytryptophan. J Biol Chem. 1957 Feb;224(2):803–810. [PubMed] [Google Scholar]
- VANE J. R., COLLIER H. O., CORNE S. J., MARLEY E., BRADLEY P. B. Tryptamine receptors in the central nervous system. Nature. 1961 Sep 9;191:1068–1069. doi: 10.1038/1911068a0. [DOI] [PubMed] [Google Scholar]
- VANE J. R. The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation. Br J Pharmacol Chemother. 1959 Mar;14(1):87–98. doi: 10.1111/j.1476-5381.1959.tb00933.x. [DOI] [PMC free article] [PubMed] [Google Scholar]